CNS
- Ref-No. Technology
-
01-00986
Non-invasive and high-throughput monitoring of exon-specific isoform expression
-
01-01045
Ex vivo method for determination of oxidative stress and diagnosis of ferroptosis-associated diseases
- 03-00367 Targeting of Autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in Alzheimer’s and vascular dementia
-
03-00471
A FRET-based method to measure seeding activity of misfolded protein species in complex biological samples
-
03-00493
Self-Organizing Human 2D Neuromuscular Junction Model and 3D Neuromuscular Organoids
-
11-00068
Dream Complex Inhibitors for Treating Medical Conditions Induced by Circadian Rhythm Disruption
-
15-00617
Spider silk/fibrin implant for the regeneration of injured spinal cord
-
15-00785
Novel CARs for the Treatment of Multiple Sclerosis and Alzheimer´s Disease
-
21-00019
Microelectrode array with combined optical stimulation
-
21-00027
Ferulic acid derivatives as efficient neuroprotective agent and memory enhancer
-
21-00035
Novel Therapy for Treatment of Alzheimer´s Disease
-
23-00046
microRNA Signature Indicates Risk for Cognitive Decline
-
23-00054
Vinpocetine inhibiting PDE1, a target for disease modifying therapy of synucleinopathies like multiple system atrophy (MSA)
-
23-00064
Treating dementia and other brain disorders with natural glycans
- 23-00065 Novel treatment of dementia-associated tauopathies
-
23-00069
NMDAR targeted CAAR-T cell therapy
- 23-00074 Treating C9orf72 ALS/FTD with active vaccination
-
23-00075
HERV inhibitors for use in tauopathies
-
32-00187
HSV signature antibodies predict the development of anti-NMDA receptor encephalitis
-
33-00002
Rapid, simultaneous and non-destructive blood diagnostics using a multi-omics NMR platform
